beta-alanine has been researched along with Triple Negative Breast Neoplasms in 1 studies
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, LX | 1 |
Zhou, JX | 1 |
Calvet, JP | 1 |
Godwin, AK | 1 |
Jensen, RA | 1 |
Li, X | 1 |
1 other study available for beta-alanine and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.
Topics: Animals; Apoptosis; Benzoxazines; beta-Alanine; Cell Line, Tumor; Cell Movement; Cell Proliferation; | 2018 |